The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.
第一作者:
M A,Dimopoulos
第一单位:
Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece. mdimop@med.uoa.gr
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);硼酸化物(Boronic Acids);地塞米松(Dexamethasone);多柔比星(Doxorubicin);女(雌)性(Female);随访研究(Follow-Up Studies);肾小球滤过率(Glomerular Filtration Rate);人类(Humans);男(雄)性(Male);美法仑(Melphalan);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);泼尼松(Prednisone);预后(Prognosis);吡嗪类(Pyrazines);肾功能不全(Renal Insufficiency);存活率(Survival Rate);沙立度胺(Thalidomide);长春新碱(Vincristine)
DOI
10.1038/leu.2012.182
PMID
22763386
发布时间
2022-03-21
- 浏览77
Leukemia
423-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



